Efficacy of raltegravir in achieving virological suppression at delivery in HIV-positive pregnant women: a systematic review and meta-analysis. [PDF]
Zhang Y +5 more
europepmc +1 more source
Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025. [PDF]
van Kampen J +13 more
europepmc +1 more source
Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review. [PDF]
Gáspár Z, Lakatos B.
europepmc +1 more source
Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study. [PDF]
Rao AM +6 more
europepmc +1 more source
Efavirenz-Induced Hepatitis Mimicking Autoimmune Hepatitis: A Case Report. [PDF]
Chowdhury AH +4 more
europepmc +1 more source
Impact of HAART therapy on cognitive function in patients with HIV: a systematic review of randomized control trial. [PDF]
Al Diab Al Azzawi M +8 more
europepmc +1 more source
Integrase Strand Transfer Inhibitors for Treatment-experienced Young Adults With Perinatal HIV in the US: Immunologic, Virologic, and Anthropometric Outcomes. [PDF]
Patel K +8 more
europepmc +1 more source
Evolution and forecasting of antiretroviral therapy utilisation in British Columbia: a population-level analysis of provincial drug treatment programme data, 2014-2024. [PDF]
Lima VD, Mokhtari Jazi A, Montaner JSG.
europepmc +1 more source
Fetal Defects in Mice Treated With Integrase Strand Transfer Inhibitors: Comparison of Dolutegravir, Raltegravir, Bictegravir, and Cabotegravir. [PDF]
Mohan H +10 more
europepmc +1 more source
In Vitro and Clinical Evaluations of UGT1A1-, P-gp-, OATP1B1-, and BCRP-Mediated Drug-Drug Interactions of Belumosudil, a Potent ROCK2 Inhibitor. [PDF]
Schueller O +4 more
europepmc +1 more source

